Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
Amr MohamedBrandon TwardyMagdi A ZordokKhuram AshrafAyman AlkhoderKelly SchrappConor SteuerZhengjia ChenSuchita PakkalaRathi PillaiJ Trad WadsworthKristin HigginsJonathan J BeitlerSuresh S RamalingamTaofeek K OwonikokoFadlo R KhuriDong M ShinMadhusmita BeheraNabil F SabaPublished in: Head & neck (2019)
Weekly cisplatin was comparable in efficacy and safety to the triweekly regimen. Our analysis supports the use of weekly or triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck, with tolerability being a key factor in selection.